Study suggests those who had COVID-19 may only need one vaccine dose
People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose, according to new research from the Penn Institute of Immunology. The findings, published in
Science Immunology, suggest only a single vaccine dose may be needed to produce a sufficient antibody response. The team found that those who did not have COVID-19 called COVID naïve did not have a full immune response until after receiving their second vaccine dose, reinforcing the importance of completing the two recommended doses for achieving strong levels of immunity.
Date Time
Penn Study Suggests Those Who Had COVID-19 May Only Need One Vaccine Dose
PHILADELPHIA People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose, according to new research from the Penn Institute of Immunology. The findings, published today in Science Immunology, suggest only a single vaccine dose may be needed to produce a sufficient antibody response. The team found that those who did not have COVID-19 called COVID naïve did not have a full immune response until after receiving their second vaccine dose, reinforcing the importance of completing the two recommended doses for achieving strong levels of immunity.
Date Time
Penn Medicine Awarded Nearly $7 Million for First Year of Contract to Study Influenza Viruses
PHILADELPHIA The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has selected Penn Medicine as one of five sites across the country to serve as a Center of Excellence for Influenza Research and Response (CEIRR), with the goal of better understanding influenza viruses around the world along with learning about the viral strains that have the potential to cause pandemics. Penn Medicine has been awarded nearly $7 million in first-year funding. The contract is expected to be supported for six additional years.
Penn study suggests those who had COVID-19 may only need one vaccine dose eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
HMS Researchers Use Machine Learning to Recommend Drugs for Alzheimer s Disease Clinical Trials | News thecrimson.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thecrimson.com Daily Mail and Mail on Sunday newspapers.